Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.
Germany needs new talent for its labor market — and fresh ideas to ensure that foreign workers not only come, but also stay.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果